The Centre has also contacted five domestic and three multinational vaccine makers to understand how soon a candidate vaccine against Covid-19 will be ready. Image used for representational......
More than 2 million people have been diagnosed with coronavirus across the world, and the pharmaceutical industry is pulling out all stops to find potential treatments and vaccines for the global......
'Make in India' will be central to Mr Modi's visit to Europe and Canada. It is difficult to predict what will happen with the Rafale deal, but if it goes through, it will undoubtedly become the......
The Philippines launches probe after Sanofi reveals WHO-approved dengvaxia - a dengue vaccine - aggravates symptoms in some cases. The delay by the health ministry in approving the sale of......
The French drug maker has its vaccine approved in Mexico for all four serotypes for patients aged 9 to 45. Sanofi Pasteur, the vaccine division of drug maker Sanofi, has completed the first study......
French drug major Sanofi’s dengue vaccine discovery could open a $-1 billion opportunity in India alone. The Paris-based global drug giant announced last week that it would have the vaccine......
The government may take a hit of about Rs 40,000 crore if it accepts the recommendations of the Parthasarathi Shome panel to tax indirect transfer of Indian assets prospectively, as against the......
As corporate India unlocks value through mega deals, the Union government is smiling all the way to the bank.The government is likely to earn Rs 7,000 crore (Rs 70 billion) tax in the current......